Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Jan 15, 2003
Hemispherx Biopharma's International Team of Clinical Researchers to Present New Data on Experimental Treatment of CFS
Dec 18, 2002
Rebroadcast of Hemispherx's December 18, 2002 Conference Call Available On Company's Website or Via Telephone Replay
Dec 17, 2002
Hemispherx Presents New Data from Phase IIB Clinical Trial of RNA-based Ampligen® for Structured Treatment Interruption in HIV at DART Conference
Dec 17, 2002
Hemispherx to Host Conference Call on Recent Presentation at the 2002 DART Conference and Other Recent Developments
Dec 16, 2002
Hemispherx Files New US Patent Application on Immune-Based Alternative Treatment to HIV/AIDS
Dec 09, 2002
HEMISPHERX BIOPHARMA COMPLETES FULL ENROLLMENT OF ITS PHASE III CLINICAL TRIAL FOR CHRONIC FATIGUE SYNDROME (CFS)
Nov 25, 2002
Hemispherx Biopharma Invited to Present New Anti HIV Data at DART Conference: Phase IIB Clinical Trials of Strategic Treatment Intervention
Nov 20, 2002
Hemispherx Biopharma, Inc. Adopts Stockholder Rights Plan
Nov 18, 2002
Hemispherx Biopharma and Sigma-Aldrich Enter Agreement to Produce Hemispherx's RNA-based Ampligen® in U.S.
Nov 15, 2002
Hemispherx Announces Third Quarter Results
73
74
75
76
77
78
79
80
81
82
<<
<
>
>>
Privacy